Works matching IS 17762596 AND DT 2023 AND VI 18 AND IP 5

Results: 15

Correction to: Darolutamide: A Review in Metastatic Hormone-Sensitive Prostate Cancer.

Published in:

2023

By:

Lee, Arnold

Publication type:

Correction Notice

Real-World Treatment Sequencing in Vulnerable Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Study.

Published in:

Targeted Oncology, 2023, v. 18, n. 5, p. 707, doi. 10.1007/s11523-023-00996-0

By:

Mitani, Seiichiro;
Kito, Yosuke;
Hino, Kaori;
Kawakami, Kentaro;
Izawa, Naoki;
Hanamura, Fumiyasu;
Yamamoto, Yoshiyuki;
Shoji, Hirokazu;
Komori, Azusa;
Boku, Shogen;
Tsuchihashi, Kenji;
Kato, Kyoko;
Nonagase, Yoshikane;
Matsumoto, Toshihiko;
Furuta, Mitsuhiro;
Kawakami, Hisato

Publication type:

Article

Comparative Effectiveness of Lurbinectedin for the Treatment of Relapsed Small Cell Lung Cancer in the Post-Platinum Setting: A Real-World Canadian Synthetic Control Arm Analysis.

Published in:

Targeted Oncology, 2023, v. 18, n. 5, p. 697, doi. 10.1007/s11523-023-00995-1

By:

Boyne, Devon J.;
Dawe, David E.;
Shakir, Huma;
Joe-Uzuegbu, Ofodile;
Farah, Eliya;
Pabani, Aliyah;
Baratta, Cristina;
Brenner, Darren R.;
Cheung, Winson Y.

Publication type:

Article

Mutant HRas Signaling and Rationale for Use of Farnesyltransferase Inhibitors in Head and Neck Squamous Cell Carcinoma.

Published in:

Targeted Oncology, 2023, v. 18, n. 5, p. 643, doi. 10.1007/s11523-023-00993-3

By:

Wang, Jiayu;
Al-Majid, Dana;
Brenner, J. Chad;
Smith, Joshua D.

Publication type:

Article

Population Pharmacokinetics and Pharmacodynamics of Carfilzomib in Combination with Rituximab, Ifosfamide, Carboplatin, and Etoposide in Adult Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma.

Published in:

Targeted Oncology, 2023, v. 18, n. 5, p. 685, doi. 10.1007/s11523-023-00992-4

By:

Lin, Lan-Hsi;
Ghasemi, Mohammad;
Burke, Sarah M.;
Mavis, Cory K.;
Nichols, Jenna R.;
Torka, Pallawi;
Mager, Donald E.;
Hernandez-Ilizaliturri, Francisco J.;
Goey, Andrew K. L.

Publication type:

Article

Clinical Efficacy and Safety of First- or Second-Generation EGFR-TKIs after Osimertinib Resistance for EGFR Mutated Lung Cancer: A Prospective Exploratory Study.

Published in:

Targeted Oncology, 2023, v. 18, n. 5, p. 657, doi. 10.1007/s11523-023-00991-5

By:

Morimoto, Kenji;
Yamada, Tadaaki;
Takeda, Takayuki;
Shiotsu, Shinsuke;
Date, Koji;
Tamiya, Nobuyo;
Goto, Yasuhiro;
Kanda, Hibiki;
Chihara, Yusuke;
Kunimatsu, Yusuke;
Katayama, Yuki;
Iwasaku, Masahiro;
Tokuda, Shinsaku;
Takayama, Koichi

Publication type:

Article

Clinical Outcomes and Serum B-Cell Maturation Antigen Levels in a Real-World Unselected Population of Newly Diagnosed Multiple Myeloma Patients.

Published in:

Targeted Oncology, 2023, v. 18, n. 5, p. 735, doi. 10.1007/s11523-023-00990-6

By:

Jew, Scott;
Bujarski, Sean;
Regidor, Bernard;
Emamy-Sadr, Marsiye;
Swift, Regina;
Eades, Benjamin;
Kim, Susanna;
Eshaghian, Shahrooz;
Berenson, James R.

Publication type:

Article

Population Pharmacokinetics and Exposure–Response with Teclistamab in Patients With Relapsed/Refractory Multiple Myeloma: Results From MajesTEC-1.

Published in:

Targeted Oncology, 2023, v. 18, n. 5, p. 667, doi. 10.1007/s11523-023-00989-z

By:

Miao, Xin;
Wu, Liviawati S.;
Lin, Shun Xin Wang;
Xu, Yan;
Chen, Yang;
Iwaki, Yuki;
Kobos, Rachel;
Stephenson, Tara;
Kemmerer, Kristy;
Uhlar, Clarissa M.;
Banerjee, Arnob;
Goldberg, Jenna D.;
Trancucci, Danielle;
Apte, Amit;
Verona, Raluca;
Pei, Lixia;
Desai, Rachit;
Hickey, Kathleen;
Su, Yaming;
Ouellet, Daniele

Publication type:

Article

Results from a Real-World Multicenter Analysis of 482 Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Look at Racial Differences.

Published in:

Targeted Oncology, 2023, v. 18, n. 5, p. 727, doi. 10.1007/s11523-023-00988-0

By:

Barrientos, Jacqueline C.;
Ayed, Ayed O.;
Cha, Agnes;
Du, Senxi;
Fang, Bruno;
Hall, Ryan;
Marks, Stanley M.;
Peng, Eileen;
Rhodes, Joanna M.;
Ryan, Kellie;
Winters, Sharon B.;
Yeung, Percy L.;
Hou, Jing-Zhou

Publication type:

Article

Summary of Research: Adjuvant Nivolumab Plus Ipilimumab Versus Placebo for Localized Renal Cell Carcinoma After Nephrectomy (CheckMate 914): A Double-Blind, Randomized, Phase 3 Trial.

Published in:

Targeted Oncology, 2023, v. 18, n. 5, p. 639, doi. 10.1007/s11523-023-00987-1

By:

Motzer, Robert J.;
Russo, Paul;
Grünwald, Viktor;
Tomita, Yoshihiko;
Zurawski, Bogdan;
Parikh, Omi;
Buti, Sebastiano;
Barthélémy, Philippe;
Goh, Jeffrey C.;
Ye, Dingwei;
Lingua, Alejo;
Lattouf, Jean-Baptiste;
Albigès, Laurence;
George, Saby;
Shuch, Brian;
Sosman, Jeffrey;
Staehler, Michael;
Vázquez Estévez, Sergio;
Simsek, Burcin;
Spiridigliozzi, Julia

Publication type:

Article

Impact of Cardiovascular Comorbidities on the Effectiveness and Safety of Bevacizumab in Older Patients with Metastatic Colorectal Cancer.

Published in:

Targeted Oncology, 2023, v. 18, n. 5, p. 717, doi. 10.1007/s11523-023-00986-2

By:

Gouverneur, Amandine;
Favary, Clélia;
Jové, Jérémy;
Rouyer, Magali;
Bignon, Emmanuelle;
Salvo, Francesco;
Tchalla, Achille;
Paillaud, Elena;
Aparicio, Thomas;
Noize, Pernelle

Publication type:

Article

A Retrospective Analysis of Biliary Tract Cancer Patients Presented to the Molecular Tumor Board at the Comprehensive Cancer Center Munich.

Published in:

Targeted Oncology, 2023, v. 18, n. 5, p. 767, doi. 10.1007/s11523-023-00985-3

By:

Zhang, Danmei;
Dorman, Klara;
Heinrich, Kathrin;
Weiss, Lena;
Boukovala, Myrto;
Haas, Michael;
Greif, Philipp A.;
Ziemann, Frank;
Beyer, Georg;
Roessler, Daniel;
Goni, Elisabetta;
Renz, Bernhard;
D'Haese, Jan G.;
Kunz, Wolfgang G.;
Seidensticker, Max;
Corradini, Stefanie;
Niyazi, Maximilian;
Ormanns, Steffen;
Kumbrink, Jörg;
Jung, Andreas

Publication type:

Article

Darolutamide: A Review in Metastatic Hormone-Sensitive Prostate Cancer.

Published in:

Targeted Oncology, 2023, v. 18, n. 5, p. 793, doi. 10.1007/s11523-023-00984-4

By:

Lee, Arnold

Publication type:

Article

Molecularly Stratified Treatment Options in Primary Refractory DLBCL/HGBL with MYC and BCL2 or BCL6 Rearrangements (HGBL, NOS with MYC/BCL6).

Published in:

Targeted Oncology, 2023, v. 18, n. 5, p. 749, doi. 10.1007/s11523-023-00983-5

By:

Witte, Hanno M.;
Riedl, Jörg;
Künstner, Axel;
Fähnrich, Anke;
Ketzer, Julius;
Fliedner, Stephanie M. J.;
Reimer, Niklas;
Bernard, Veronica;
von Bubnoff, Nikolas;
Merz, Hartmut;
Busch, Hauke;
Feller, Alfred;
Gebauer, Niklas

Publication type:

Article

FDA Approvals of Oncology Drugs for Tissue-Agnostic Indications.

Published in:

Targeted Oncology, 2023, v. 18, n. 5, p. 777, doi. 10.1007/s11523-023-00982-6

By:

Zettler, Marjorie E.

Publication type:

Article